Patientensicherheit in der Rheumatherapie

Volume: 80, Issue: 5, Pages: 418 - 424
Published: Mar 11, 2021
Abstract
Methotrexate (MTX) is the most commonly prescribed disease-modifying drug in the treatment of rheumatic diseases. Regular laboratory testing is recommended to recognize side effects, such as hepatotoxicity and myelotoxicity as well as decreases in renal function that may cause toxic MTX accumulation. Additionally, folic acid is recommended as prophylaxis against specific side effects. In this study we investigated whether laboratory monitoring...
Paper Details
Title
Patientensicherheit in der Rheumatherapie
Published Date
Mar 11, 2021
Volume
80
Issue
5
Pages
418 - 424
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.